Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05591274 · ClinicalTrials.gov registry record · NA
Virtual Reality Technology for Vasectomy Pain Modulation
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT05591274 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 120 participants.
The verdict
NCT05591274, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will evaluate whether or not wearing a virtual reality (VR) headset reduces pain and anxiety in patients undergoing vasectomy. The headset being used is the SmileyScope virtual reality interface, a device already undergoing study for approval by the U.S. Food and Drug Administration (FDA) to reduce pain and anxiety in patients aged 4 years and older undergoing needle blood draw or injection procedures. In this study, the SmileyScope virtual reality interface is considered an investigational device because it is not yet approved for use in adult males undergoing vasectomy.
Interventions
- DEVICE SmileyScope Virtual Reality Headset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-11-17 |
| Est. Completion | 2024-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05591274
The ClinicalTrials.gov registry entry for NCT05591274 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmileyScope Virtual Reality Headset is the first listed.
NCT05591274 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05591274 about?
NCT05591274 is a clinical study titled "Virtual Reality Technology for Vasectomy Pain Modulation". This study will evaluate whether or not wearing a virtual reality (VR) headset reduces pain and anxiety in patients undergoing vasectomy. The headset being used is the SmileyScope virtual reality interface, a device already undergoing study for approval by the U.S. Food and Drug Administration (FDA)...
What is the current status of trial NCT05591274?
This trial is currently terminated. It is a NA study. The enrollment target is 120 participants. The study started on 2022-11-17. Estimated completion is 2024-03-28.
What interventions are being tested in trial NCT05591274?
The interventions under investigation include: SmileyScope Virtual Reality Headset (DEVICE).
Who is sponsoring clinical trial NCT05591274?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.